This Obesity Drug Cuts Calorie Intake by 72% Without Dieting
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for hunger and reward in patients treated with tirzepatide. A recent study has shown that tirzepatide, a medication commonly prescribed for type 2 diabetes and weight management, led to greater reductions in body weight, food consumption, and various appetite-related measures when [...]


What's Your Reaction?






